journal article·2020-10-14

DNA Framework-Supported Electrochemical Analysis of DNA Methylation for Prostate Cancers

Shixing Chen, Jing Su, Zhihan Zhao, Yuan Shao, Yanzhi Dou, Fuwu Li, Wangping Deng, Jiye Shi, Qian Li, Xiaolei Zuo, Shiping Song, Chunhai Fan

Nano Letters· Volume 20· Issue 10
Publisher page

Abstract

Epigenetic alterations hold great promise as biomarkers for early stage cancer diagnosis. Nevertheless, direct identification of rare methylated DNA in the genome remains challenging. Here, we report an ultrasensitive framework nucleic acid-based electrochemical sensor for quantitative and highly selective analysis of DNA methylation. Notably, we can detect 160 fg of methylated DNA in million-fold unmethylated DNA samples using this electrochemical methylation-specific polymerase chain reaction (E-MSP) method. The high sensitivity of E-MSP enables one-step detection of low-abundance methylation at two different genes in patient serum samples. By using a combination test with two methylation alterations, we achieve high accuracy and sensitivity for reliable differentiation of prostate cancer and benign prostate hypertrophy (BPH). This new method sheds new light on translational use in early cancer diagnosis and in monitoring patients' responses to therapeutic agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Epigenetics and DNA Methylation · RNA modifications and cancer · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Shanghai Institute of Microsystem and information Technology, Chinese Academy of Sciences, Shanghai, 200050, China

Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China

Department of Urology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai 201801, China

Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China

School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Jiao Tong University, Shanghai 200240, China

Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acids Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (51)

Show source-provided references
1. 10.3322/canjclin.55.2.7410.3322/canjclin.55.2.74 ↗
2. 10.1038/bjc.2011.14310.1038/bjc.2011.143 ↗
3. 10.1002/cncr.2048010.1002/cncr.20480 ↗
4. 10.3322/canjclin.54.1.810.3322/canjclin.54.1.8 ↗
5. 10.1038/nrclinonc.2013.8010.1038/nrclinonc.2013.80 ↗
6. 10.1016/j.canlet.2005.11.02710.1016/j.canlet.2005.11.027 ↗
7. 10.1021/acs.nanolett.8b0311110.1021/acs.nanolett.8b03111 ↗
8. 10.1038/nrg323010.1038/nrg3230 ↗
9. 10.1038/nbt.168510.1038/nbt.1685 ↗
10. 10.1158/1538-7445.AM2014-135510.1158/1538-7445.AM2014-1355 ↗
11. 10.1073/pnas.93.18.982110.1073/pnas.93.18.9821 ↗
12. 10.1158/1078-0432.CCR-09-330410.1158/1078-0432.CCR-09-3304 ↗
13. 10.1021/nl504522n10.1021/nl504522n ↗
14. 10.1021/acs.nanolett.6b0133710.1021/acs.nanolett.6b01337 ↗
15. 10.1021/nl501340d10.1021/nl501340d ↗
16. 10.1021/acsami.5b0143810.1021/acsami.5b01438 ↗
17. 10.1002/adma.20170378710.1002/adma.201703787 ↗
18. 10.1002/adfm.20150094010.1002/adfm.201500940 ↗
19. 10.1021/ac503986310.1021/ac5039863 ↗
20. 10.1039/c3cs35518g10.1039/c3cs35518g ↗
21. 10.1002/adma.20100276710.1002/adma.201002767 ↗
22. 10.1021/acsami.7b0598110.1021/acsami.7b05981 ↗
23. 10.1021/acsami.7b1792710.1021/acsami.7b17927 ↗
24. 10.1021/jacs.7b0978910.1021/jacs.7b09789 ↗
25. 10.1016/S0090-4295(02)01949-010.1016/S0090-4295(02)01949-0 ↗
26. 10.1158/1078-0432.CCR-11-209010.1158/1078-0432.CCR-11-2090 ↗
27. 10.1007/s13277-013-1515-310.1007/s13277-013-1515-3 ↗
28. 10.1586/erm.09.1010.1586/erm.09.10 ↗
29. 10.1002/pros.2245910.1002/pros.22459 ↗
30. 10.1002/jcb.1074010.1002/jcb.10740 ↗
31. 10.1016/j.canlet.2006.03.02010.1016/j.canlet.2006.03.020 ↗
32. 10.1158/1078-0432.CCR-06-284610.1158/1078-0432.CCR-06-2846 ↗
33. 10.3892/or.2011.157610.3892/or.2011.1576 ↗
34. 10.1158/0008-5472.CAN-05-444710.1158/0008-5472.CAN-05-4447 ↗
35. 10.1016/j.fertnstert.2007.10.07510.1016/j.fertnstert.2007.10.075 ↗
36. 10.1038/nprot.2016.07110.1038/nprot.2016.071 ↗
37. 10.1038/nchem.227010.1038/nchem.2270 ↗
38. 10.1038/nchem.136710.1038/nchem.1367 ↗
39. 10.1039/C4SC03135K10.1039/C4SC03135K ↗
40. 10.1021/acs.analchem.6b0023010.1021/acs.analchem.6b00230 ↗
41. 10.1021/acsami.7b0455310.1021/acsami.7b04553 ↗
42. 10.1016/j.aca.2013.01.02610.1016/j.aca.2013.01.026 ↗
43. 10.1016/j.snb.2015.07.03010.1016/j.snb.2015.07.030 ↗
44. 10.1016/j.matt.2019.08.00810.1016/j.matt.2019.08.008 ↗
45. 10.1016/j.urolonc.2009.05.01010.1016/j.urolonc.2009.05.010 ↗
46. 10.1038/nature0776210.1038/nature07762 ↗
47. 10.1089/gtmb.2010.026210.1089/gtmb.2010.0262 ↗
48. 10.7754/Clin.Lab.2013.13070110.7754/Clin.Lab.2013.130701 ↗
49. 10.1002/ijc.2004110.1002/ijc.20041 ↗
50. 10.1016/j.canlet.2005.11.00210.1016/j.canlet.2005.11.002 ↗
51. 10.1002/path.210610.1002/path.2106 ↗